CN113061581A - Goat-derived bovine herpes virus type 1 strain and application thereof - Google Patents

Goat-derived bovine herpes virus type 1 strain and application thereof Download PDF

Info

Publication number
CN113061581A
CN113061581A CN202110301274.4A CN202110301274A CN113061581A CN 113061581 A CN113061581 A CN 113061581A CN 202110301274 A CN202110301274 A CN 202110301274A CN 113061581 A CN113061581 A CN 113061581A
Authority
CN
China
Prior art keywords
ala
leu
arg
gly
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110301274.4A
Other languages
Chinese (zh)
Inventor
郭爱珍
朱杰
陈曦
王琛
彭清洁
陈颖钰
胡长敏
陈建国
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huazhong Agricultural University
Original Assignee
Huazhong Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huazhong Agricultural University filed Critical Huazhong Agricultural University
Priority to CN202110301274.4A priority Critical patent/CN113061581A/en
Publication of CN113061581A publication Critical patent/CN113061581A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16721Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention belongs to the technical field of animal infectious disease prevention and treatment, and particularly relates to a Goat-derived bovine herpes virus type 1 strain BoHV-1/Goat/CHN/HB 01/2016. The virus strain is separated from excrement of diarrhea goats, and the replication capacity of the virus strain is weakened through virus titer, one-step growth curve, plaque size and other results in vitro MDBK cells. The genome of the virus has the full length of 133,971bp, the GC content is up to 71 percent, and the virus belongs to a BoHV-1.1 subtype through comparison analysis of a gC fragment, wherein specific mutations exist in gB, gK, gM and VP8 proteins and can be related to the pathogenicity of strains. After the strain attacks the cattle, the virulence of the strain is weakened through clinical symptom scoring, nasal cavity detoxification and lung tissue pathological changes. The invention lays an important foundation for researching the pathogenicity and cross-species transmission mechanism of BoHV-1, and provides an important material for clinical vaccine development.

Description

Goat-derived bovine herpes virus type 1 strain and application thereof
Technical Field
The invention belongs to the technical field of animal infectious disease prevention and treatment, and particularly relates to a goat-derived bovine herpes virus type 1 strain.
Background
Bovine herpes virus type 1 (Bovine herpesvirus-1, BoHV-1) belongs to the genus varicella (Varicelovirus) of the family Herpesviridae (Herpesviridae) sub-family α -herpesvirus (Alphaherpesviridae), also known as Bovine infectious rhinotracheitis virus (IBRV). BoHV-1 is the etiological agent of infectious bovine rhinotracheitis, and can cause cattle to develop acute, febrile and contact infectious diseases, and the main clinical manifestations include upper respiratory tract and tracheitis, mucositis, hyperpyrexia, nasal fluid, dyspnea, abortion, etc. After BoHV-1 infection, the body can be immunosuppressed, secondary bacterial or other viral infection can be caused, and severe pneumonia is caused, which is called Bovine respiratory disease syndrome (BRDC), also called as heat of transport, and causes great loss to the cattle industry in the world.
BoHV-1 primarily infects cattle and buffalos, and serological evidence also suggests infection of other artiodactyls. The positive rate of neutralizing antibodies of BoHV-1 in Turkey goat flock was 20.9%; the positive rate of the neutralizing antibody in the sheep is 10.7-28.4%; the seropositivity rates of Egypt sheep and goat BoHV-1 infection are 23.8% and 27.6%, respectively; in Canada, the neutralization antibody positive rate of sheep BoHV-1 is 10.8%; BoHV-1 seropositivity in goats was determined to be 13.7% in the Korean neutralization test. The research shows that: there is a significant correlation between infection between goats and cattle compared to sheep, and goats can therefore be considered as potential storage hosts for BoHV-1. The diversity of the viral host adds difficulty to the control and prevention of the disease, and few studies on the isolation and identification of goat-derived BoHV-1 strains currently limit the mechanism of cross-species transmission of BoHV-1 between goats and cattle. The inventor obtains a goat source BoHV-1 from diarrhea goat feces through separation and identification of virus for the first time, and verifies that the virus has natural attenuated virulence in vivo and in vitro, so that a good natural material is provided for researching the pathogenic and cross-species transmission mechanism of BoHV-1 and developing vaccines.
Disclosure of Invention
The invention aims to provide a goat-derived Bovine herpes virus-1 (Bovine herpesvirus-1) strain, which can be used as a target for researching BoHV-1 pathogenesis and cross-species transmission mechanism, can also be used as a better material for vaccine development, and has important significance for the prevention and control of Bovine herpes virus.
The technical scheme of the invention is as follows:
the applicant obtains a BoHV-1 strain by separating, identifying and purifying the feces of diarrhea goats from a certain Goat farm of Huanggang, Hubei province in 5 months in 2016, the applicant names the strain as bovine herpes virus 1 BoHV-1/coat/CHN/HB 01/2016, and the strain is preserved in China Center for Type Culture Collection (CCTCC) of Wuhan university, Wuhan city, Hubei province in 12 months and 11 days in 2020, with the preservation number of CCTCC NO: v202092.
In vitro MDBK cells, the replication capacity of the strain is proved to be lower than that of a reference strain BoHV-1 Cooper through the results of virus plaques, one-step growth curves, virus titer and the like.
Extracting the whole genome of the virus to perform high-throughput sequencing to obtain a complete virus genome sequence with the genome total length of 133,971bp and the GC content of 71 percent. The virus belongs to the BoHV-1.1 subtype by alignment analysis of the gC fragment. In comparison with the reference strain Cooper, there are specific mutations in the gB, gK, gM, VP8 proteins that may be correlated with the virulence of the strain.
After the cattle is attacked by the virus, the pathogenicity of the strain is lower than that of a reference strain Cooper through clinical symptom scoring, nasal cavity detoxification and lung tissue pathological change.
The invention has the following advantages:
the bovine herpes virus type 1 strain is separated and identified from a diarrhea goat excrement sample for the first time, and the strain shows attenuated virulence, so that an important basis is laid for researching the virulence and cross-species propagation mechanism of the BoHV-1 virus, and an important material is provided for developing a bovine infectious rhinotracheitis vaccine with better clinical safety.
The detailed technical scheme is described in the detailed description.
Drawings
FIG. 1: is a PCR gel map for identifying gG and TK genes of BoHV-1 in a goat diarrhea sample. Description of reference numerals: lanes 1-3 detect the TK gene, and lanes 4-6 detect the gG gene. Lanes 1 and 4 are goat diarrhea samples, lanes 2 and 5 are reference strain Cooper strains as positive controls, lanes 3 and 6 are negative controls, and lane 7 is DL 2000DNA marker.
FIG. 2: is a cytopathic map formed by the BoHV-1 HB01 strain with a scale of 400 μm and with reference numbers indicating: fig. 2A is a cytopathic map formed by goat-derived HB01 strain, and fig. 2B is a negative control map.
FIG. 3: is a morphological map of BoHV-1 HB01 virus particles observed under an electron microscope.
FIG. 4: is the titer stability of the BoHV-1 HB01 virus during passaging.
FIG. 5: is a BoHV-1 HB01 virus growth graph, infecting the virus at 0.1 MOI.
FIG. 6: is a comparison of the size of plaques formed by the BoHV-1 HB01 virus.
FIG. 7: is a gB gene evolutionary tree of BoHV-1 HB01 virus.
FIG. 8: is the gC gene evolutionary tree of the BoHV-1 HB01 virus.
FIG. 9: the temperature change of boHV-1 HB01 virus attacking cattle after the virus attack.
FIG. 10: is the change of clinical symptom scores after BoHV-1 HB01 virus challenge cattle.
FIG. 11: is the daily gain of BoHV-1 HB01 virus after challenge of cattle.
FIG. 12: is to detect the nasal detoxification after BoHV-1 HB01 virus challenge cattle.
FIG. 13: is the histopathological result of the lung of the cattle attacked by the BoHV-1 HB01 virus. Description of reference numerals: FIG. 13A is the pathological observation result of the lung of a bovine after the challenge with BoHV-1 HB01 strain, FIG. 13B is the pathological observation result of the lung of a bovine after the challenge with BoHV-1 Cooper strain, and C in FIG. 13 is the pathological observation result of the lung of a bovine inoculated with DMEM, and the scale in the graph is 50 μm.
Detailed Description
The present invention will be described in detail below with reference to specific examples.
Example 1: isolation and identification of strains
1. Isolation of strains
Collecting a stool sample of a diarrhea goat in a certain goat farm in Huanggang city, preserving at low temperature and rapidly transporting to a laboratory. Samples are centrifuged at 8000R/min for 10min, 200 mu L of supernatant is taken, virus DNA in the samples is extracted by using a DNA extraction kit (purchased from Beijing Quanyu Co., Ltd.), and two pairs of primers gG-F/R, TK-F/R are designed according to the BoHV-1 strain sequence (genome GenBank accession number is AJ004801) for PCR identification. Primers were synthesized by commercial organisms, and the sequences of the primers are shown in Table 1. The resulting target band was as expected (FIG. 1), and BoHV-1 was identified as positive in the goat diarrhea sample.
Table 1: primers for detecting gG and TK genes of BoHV-1 in clinical samples
Figure BDA0002986350200000031
To a 6-well plate full of MDBK cells, 400. mu.L of the supernatant of the disease material for BoHV-1 positive identification by PCR as described above was added, and the mixture was incubated at 37 ℃ for 60 min. Discarding supernatant, rinsing with sterile PBS for 3 times, adding 2mL DMEM medium containing 2% fetal calf serum, and standing at 37 deg.C with 5% CO2Cultured in an incubator. After inoculation of the disease material for 18-24h, obvious cytopathy can be observed, the cells become round and have high refractivity, and the cells are gathered into a grape-shaped cluster (figure 2A), and negative control cells have no obvious change (figure 2B).
2. Identification of strains
The virus culture supernatant is subjected to PCR identification of gG and TK fragments after DNA is extracted according to the method, and an expected obvious band is obtained. The PCR product was recovered and purified using agarose gel DNA recovery kit (purchased from Tiangen Biotechnology Ltd.), then ligated to TOPO vector (purchased from Beijing Ederlie Ltd.), the ligation product was transformed into DH 5. alpha. E.coli competent plasmid, inoculated to ampicillin resistant common plate, cultured overnight at 37 ℃, selected for suitable single colony, PCR-identified and the positive single colony was sent to commercial organism for sequencing. The obtained gG (SEQ ID No.1) and TK (SEQ ID No.2) fragments were aligned in Basic Local Alignment Search Tool (BLAST) in GenBank, and both gG and TK were found to have 100% similarity to the corresponding sequences of BoHV-1.
After a large amount of virus was propagated, 8000 Xg of the virus solution was centrifuged for 30min, and the supernatant was filtered with a 0.22 μm filter to remove cell debris, followed by ultracentrifugation of the virus solution at 4 ℃ at 25,000 Xg for 2 h. Discarding the supernatant, fixing the precipitate with glutaraldehyde, dropping the sample on a copper net for adsorption for 5min, dropping 20g/L phosphotungstic acid after drying for negative dyeing for 1min, and then taking a picture under a Hitachi H-7000FA electron microscope for observation. The virus size was approximately 160nm, and it appeared as a spherical, enveloped, and the nucleocapsid of the virion was observed to have a regular hexagonal structure, conforming to the basic characteristics of a BoHV-1 virion (fig. 3).
In conclusion, the isolated virus was identified as bovine herpes virus type 1 and the Applicant named it BoHV-1/Goat/CHN/HB 01/2016.
Example 2: biological Properties of the BoHV-1/Goat/CHN/HB01/2016 Strain
1. Subculture stability of strains
The strain BoHV-1 HB01 was serially passaged through MDBK cells to passage 10, and PFU (plate Forming Unit) was determined for each passage. Diluting the virus to be detected by 10 times, and taking 10-3,10-4,10-5,10-6And 10-75 dilutions, plating MDBK cells, 3 wells per dilution, 0.2mL per well, 5% CO at 37 ℃2Incubate in the incubator, aspirate the virus solution after 2h, and add 1ml of agarose overlay fluid (1% serum in 2 × DMEM: 2% agarose 1:1) per well. After the culture medium is solidified, placingCulturing in 37 deg.C incubator, 48 hr, fixing with 10% neutral formaldehyde for 24 hr, staining cells with crystal violet (0.35%, w/v), washing with water after 20min, oven drying, calculating number of plaques, and calculating virus titer (PFU) according to formula. The virus titer calculation formula is as follows: viral content per ml-average number of plaques triplicated at the same dilution × 5
The result shows that the virus gradually increases the toxic valence to the 4 th generation after MDBK cell passage and is stable at 10%7PFU/mL or so (FIG. 4).
2. Growth Curve plotting of strains
Infecting MDBK cells with 0.1MOI virus, harvesting cultures at 0h, 3h, 6h, 9h, 12h, 15h, 18h, 21h, 24h, 30h, 36h, 42h, 48h, 54h, 60h, 66h and 72h after infection respectively to a refrigerator at minus 80 ℃, repeatedly freezing and thawing twice, measuring virus toxicity according to the method, and finally drawing a growth curve. BoHV-1 Cooper strain was used as a reference control strain.
The results show that the overall growth trend of the strain is substantially consistent with that of the reference strain BoHV-1 Cooper. The titer of the BoHV-1 HB01 strain rises faster during 15-36h of infection and reaches a plateau after 42h (10 h)7.3PFU/mL) (FIG. 5).
3. Plaque size of strains
The plaque diameter of the virus was observed under a microscope after fixed staining according to the titer determination method. 40-50 plaques were selected for measurement calculation, and the plaque diameter formed by the strain was 200 μm on average, and the significance was less than that of the reference strain BoHV-1 Cooper (p <0.0001) (FIG. 6).
Analysis of the biological properties of the virus indicates that the isolated strains of the invention exhibit hypotoxicity in vitro.
Example 3: genomic sequencing of BoHV-1/Goat/CHN/HB01/2016 strain
Extracting the genome of the isolate by using a virus DNA extraction kit (purchased from QAIGEN, Germany), detecting the integrity and concentration of the genome extraction, and sending the qualified DNA sample to Shenzhen Hua Dagen science and technology service GmbH for sequencing and assembling. Homologous gene prediction and annotation was performed based on the reference sequence AJ 004801.
The strain obtained by separation, identification and purification is sequenced and then data assembly is carried out, and finally 1 whole genome sequence is obtained. The result shows that the genome has the full length of 133,971bp, the GC content is up to 71 percent, 73 open reading frames are contained, and 73 proteins are coded. The gB sequences of the isolated and identified BoHV-1 HB01 strain, bovine herpes viruses (BoHV-1 and BoHV-5) and goat herpes virus (CapHV-1) were subjected to evolutionary analysis using MEGA7.0 software, and the analysis was calculated by the orthodox method, giving a Bootstrap value of 1000 times. The results are shown in FIG. 7, and the evolutionary analysis shows that the goat-derived isolate identified by the present invention belongs to bovine herpes virus, and is far away from goat herpes virus CapHV-1. The 451bp sequence of gC was selected for BoHV typing analysis and the results are shown in FIG. 8. The result shows that the strain separated and identified by the invention belongs to BoHV-1.1.
The UL53(SEQ ID No.3), UL27(SEQ ID No.4), UL10(SEQ ID No.5) and UL47(SEQ ID No.6) genes of the strains were translated into glycoprotein gK, gB, gM and VP8 amino acid sequences, respectively, and compared to the published BoHV-1 strain. The results showed that the gK protein (SEQ ID No.7) was missing 6 amino acids (33R, 38L, 202R, 231A, 267A, 274A, respectively) compared to the reference strain Cooper strain. gB (SEQ ID No.8) has a deletion of tyrosine (Y) at position 176, compared to the reference strain Cooper strain. gM (SEQ ID No.9) has the 169-172 continuous mutation (LAPP > AGAA), the 313-317 continuous mutation (RAAAR > GLPLG) and the 406-412 insertion mutation (RPPTIPL > ARQPYR) compared with the reference strain Cooper strain. VP8(SEQ ID No.10) has consecutive mutations at positions 13-15 (RAV > PRR), deletion mutation at positions 33-47 (AGRPARCGRRGRGA > LLDALRAADAEAAER), and positions 365-375 and 381-396 compared to the Cooper strain of the reference strain.
Example 4: virulence of the BoHV-1/Goat/CHN/HB01/2016 strain
The 9 test calves were randomly divided into 3 groups and tested negative for herpes virus type 1. Group 1 inoculation 4X 107.0TCID50BoHV-1 HB01, group 2 seed 4X 107.0TCID50BoHV-1 Cooper (R), control group was inoculated with 4mL of DMEM in a nasal inoculation. Within 14 days after inoculation, each timeBody temperature was measured 2 times a day, clinical symptoms were recorded, nasal, ocular and anal swabs were collected for virus detection, and serum was collected at 0, 7, 14, 21, 28 for antibody detection. After cessation of detoxification of nasal cavities was determined on day 18 post inoculation, dexamethasone was injected intramuscularly at 2.5mg/kg, followed by continued daily collection of nasal, ocular and anal swabs. On day 28 after inoculation, all experimental cattle were subsequently euthanized and tissue and organ samples were collected. Cattle were weighed before inoculation and before euthanasia.
The body temperature of the cattle with the toxin attacking increased significantly, reaching 40 ℃ at day 4, and then decreased gradually, but still higher than the normal body temperature, and the body temperature of the cattle with HB01 group was significantly lower than that of the Cooper group (FIG. 9). All of the challenged cattle exhibited clinical symptoms (marked nasal and ocular secretions, lassitude, anorexia) which continued until day 14, during which period the Cooper group cattle had a higher clinical symptom score than the HB01 group (fig. 10). The average weight gain of cattle in the control group is 300 g/day, which is obviously higher than that of 2 challenge groups, while the average weight gain of cattle in the HB01 group is higher than that of Cooper group (FIG. 11).
Viruses were detected in the nasal cavities of cattle in Cooper group and HB01 group (FIG. 12), and the peak period of detoxification was 2-5 days, which reached 10-4.67TCID50mL and 10-3.8TCID50mL, until no virus was detected on day 9, and the nasal cavity detoxification of cattle in Cooper group was higher than that in HB01 group as a whole. On day 3, the bull eye swabs of Cooper group and HB01 group all cleared toxins, which respectively reached 10- 3.76TCID50mL and 10-2.39TCID50mL (Table 2). On day 4, the cow anus swab in Cooper group was detoxified to 10-2.67TCID50mL, whereas the HB01 group bovine anus swab detoxified for 3 days at 10-(1.57-1.8)TCID50mL (Table 2).
Table 2: BoHV-1 cow receiving posterior eye swab and anus swab detoxification method
Figure BDA0002986350200000061
After dexamethasone injection, cattle in the Cooper group developed mild symptoms including nasal and ocular secretions, cough, mental depressionDepression, etc. the nasal cavity toxin expelling time is 3-4 days after injection, and the maximum toxin expelling amount is 10-1.77TCID50Whereas neither HB01 nor control cattle detected detoxification (FIG. 12).
After killing the cattle on day 28, the lung tissue was fixed with formaldehyde for histopathological observation. The results showed that the alveolar structure of HB01 group was destroyed, the alveolar wall was slightly thickened and a small number of lymphoid cells were present in the alveolar space (FIG. 13A), the normal alveolar structure of Cooper group cattle had disappeared, and a large number of necrotic cells and inflammatory cells were present in the alveolar space (FIG. 13B). Whereas the alveolar structure of the normal control group remained intact and the alveolar space was free of lymphoid cells (FIG. 13C).
In conclusion, the bovine herpes virus 1BoHV-1/Goat/CHN/HB01/2016 strain obtained by the invention has weaker virulence in vitro and in vivo than that of a reference strain BoHV-1 Cooper strain, which lays an important foundation for researching the virulence and cross-species transmission mechanism of the bovine herpes virus type 1, provides an important material for the development of a vaccine with better clinical safety, and has important significance for the prevention and control of the bovine herpes virus type 1.
Appendix: the term in the specification states:
bovine herpes virus type 1BoHV-1/Goat/CHN/HB01/2016 strain, represented by BoHV-1 HB 01.
A reference strain of bovine herpes virus type 1, BoHV-1 Cooper strain (KU198480), is designated BoHV-1 Cooper.
Description of sequence listing:
SEQ ID NO.1 is the gG gene nucleotide sequence of the BoHV-1 HB01 strain, and the sequence length is 1860 bp.
SEQ ID NO.2 is the TK gene nucleotide sequence of BoHV-1 HB01 strain, and the sequence length is 868 bp.
SEQ ID NO.3 is the UL53 gene nucleotide sequence of the BoHV-1 HB01 strain, and the sequence length is 999 bp.
SEQ ID NO.4 is the UL27 gene nucleotide sequence of BoHV-1 HB01 strain, and the sequence length is 2799 bp.
SEQ ID NO.5 is the UL10 gene nucleotide sequence of the BoHV-1 HB01 strain, and the sequence length is 1237 bp.
SEQ ID NO.6 is the UL47 gene nucleotide sequence of the BoHV-1 HB01 strain, and the sequence length is 2219 bp.
SEQ ID NO.7 is the gK protein amino acid sequence of the BoHV-1 HB01 strain, encoding 332 amino acids.
SEQ ID NO.8 is the gB protein amino acid sequence of the BoHV-1 HB01 strain, encoding 932 amino acids.
SEQ ID NO.9 is the gM protein amino acid sequence of the BoHV-1 HB01 strain, encoding 412 amino acids.
SEQ ID NO.10 is the VP8 protein amino acid sequence of BoHV-1 HB01 strain, encoding 738 amino acids.
Sequence listing
<110> university of agriculture in Huazhong
<120> goat-derived bovine herpes virus type 1 strain and application thereof
<160> 10
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1860
<212> DNA
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 1
ccgaccgcct cctacaccag atgctgacct ttgactttcg cgcgcgcccc accgccgcgg 60
agctgctgga gcaccccgtc ttcggtgcgg cctcggggta gccccggggg tttcccgcaa 120
aactgaggca tataaggcgc gggcaccggc aagtttggca tccacacttc gcgctgtgga 180
cacgagagcg aacgcgagcg aacgcgagcg caagcgcgag cacacgactg cgatcatgcc 240
tgccgcccgg accggcacct tggccgccgt cgccctaatc ctgctctgcg gggccgccgt 300
tttggggcgc cccgcgcccg acgacctctg tttcgccgac gtgcgccgca ctggcatggc 360
gccctcccgc ccgctggggc ccgtcctgaa cctagcggcc tcggatttga cctcgcgggt 420
ttcggtgcgc gcggtggacg cttcgcgcgg ctgcgccctg gccctcttgg acatggcgga 480
gacggtggtg cccggcggac cgcgagccgc cgacgtcgtc gacgtcggct gggcttacca 540
agacggggac tgcatggtgc ctctggcata tcgccagtac tttaactgca cggggggcgc 600
gctgcccggc caaaacgtct gcgccgggct ctctgagacc cgcatccgcg gtggctttgg 660
aacctccgac tacgcgctct acgggacgtc gctagtactg cgccccggcc tgtacgaccg 720
cgggacctac atctacttcc ttggatacgg cccagacgac atctacgtgg gcagcgtcac 780
gctcatggtg ggcgccgaca tccacaaata cccctgcggg ctggaccgag ggctcggtgt 840
ggccctgcac cacaagagcg gaccggcccg acctctgaca gaggacgacg ccaccggcga 900
ctgggcctgc ggctgcttcc ccgcccttgt tgaggttgac gcggtgtggg gcaacgtaag 960
cgccgcagag ctgggcctgg ccgacccgat cgactacgcc gacgaagggg gtgaggtcga 1020
agtgctcgag gacgaagccg ggagcgccag cggaaacctg ccgcaggacg accccgaccc 1080
cgacctcgca gattgccgga ccgtcgggct ctttagcgaa agcgacatgt tccggaccgc 1140
cagcgggccc gaatcgctgc tgatcggcgc cgttgccaag gacgtcctga cggtgcccct 1200
caatctgccg cccggccgct cttacgaggc cctgcgaaac gcatcgctgg agtgcaactc 1260
ccgcccgcgc gagaccggcg acgcagcggt ggtggtgatg tctctccagg agcccgctcg 1320
cctcgagcgc cgccccgatg cccgcgccac cgatccggag tttgggctct ttggcctgcc 1380
cgatgacccc gccgtgcggc gcggcattct catcggcctc gcgatcgctc tgctggtgct 1440
gctgttttcg ctggtgatcg tgctcgtctg cgcctgccgg ctcgcccgcg cagccaaggc 1500
tgcgcgacgc gcccgcgccg ccacgttcgc caagagcaac cccgcgtacg agccgatgct 1560
cagcgtctga tcgccggcac cccacgccgc cccgaccccg ctgtcccgcg tttacaataa 1620
acagttattc ttaccaacgt tggtgcgcct gtcgcgtgtc tattgcgagt taaaccgagt 1680
gccccaccca ggcagggcgg gggttgggcc gggccgcagc cccggctggg tatatatccc 1740
cgacgggcga ctagagatac actcgccccg cgcggctgct gcgagcgggc gaacatgcaa 1800
gggccgacat tggccgtgct gggcgcgctg ctcgccgttg cggtgagctt gcctacaccc 1860
<210> 2
<211> 868
<212> DNA
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 2
acgggctggg aaagacaaca acgggccgcg cgctcgcggc cgcttccacc gctggggagg 60
gcgtgctctt tttcccggag ccgatggcgt actggcgcac gatgtttggt acggacgcct 120
taagtgggat cctcgcggcg tctgcgcgat gcgccgcagc ctcgcacggg agcgcacgcg 180
gcgccggcgg gccggcgcac cgcgcagacg cggacgcggc gggcctggtt gcgtactacc 240
aggccaggtt cgcggccccg tacttaattt tgcacgcgcg cgtgtccgcg ctgctggcgc 300
cgcctgggcc ggcgccgggc ggcactgtga ccctcgtgtt cgaccgccac cccgtggccg 360
cgtgcctctg ctaccccttc gcccgctact gcctccgcga gatcaacgcg gaagatctgc 420
tcatgctcgc ggccgccatg cccccggaag cgcccggggc caacctcgtc gtgtgcaccc 480
tccccccggc cgagcaacag cgccgcctgg cggcgcgggc caggcccgga gaccgcgcgg 540
acgcgggctt tctggtcgct gtgcgcaatg cttacgcgct cctggtgaac acgtgcgctt 600
tcctgcgcgc ggggggcgca tggcgcgacg gctgggacgc gctggagtgg gcggacgcaa 660
atgcattggc cgcgctcgca gaccccagtt gtgatgaatg caaaatggcg ccggcgccgg 720
cgctgcgcga caccctgttc gcggcgctca agtgccgcga gctctacccg ggcggcggga 780
cgggcttgcc cgcggttcac gcctgggcgc tggacgccct ggccggccgc ctcgccgccc 840
tcgaggtgtt cgtgctggac gtgtccgc 868
<210> 3
<211> 999
<212> DNA
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 3
tcacgtctgc gcgcccagca gccgcaggcg caggttgtgc tcgtagtgca gcagcgcgat 60
gacgcccccc acgatagcgg ccaggtagag cgcctttacg agcagccccg cgagcagcgt 120
ggagcagcag ttcacgcaca cctttctgat cccgctctcg ccgccatcgc cgccatcgcc 180
ggcgcacgtg cccccgcgcc gccgcggctt gcggtatagc agcgagacca gttccaatcc 240
ggcaaagagg gcgacgtgaa cccacgccca gattttcagg tacagcgggt aggcggccgc 300
gcaggggtgc gttatgccga cgctgctggc cgccgcaatc cgcgcgccga gccgcgccaa 360
gccctccgca agcagcggga gagcagcccg ggggcgccag gcgcagccca gggggtcgag 420
gcggaagttg acagcaagcg cgcgccggcg cgccgagagc tcgcacatga gccgcgcgag 480
cttcgtgtac gggccgtggc cgactacggc cgcgagcgcg gcggcagcgt agttgagggt 540
gtagccgccg gggctgagga agtcggcgtc gttgcggcaa atgccgaaca tgcgccgctc 600
ctggcgcagg tacacgaacg cgacgtacag cagccatgcc agcagcgcgc tgcgagcctg 660
cgcggaccac aggtaggcgc ggcaatcgcg cgcgccggcc acggcgcgca cgcggccgtg 720
cagcgcttcg tcgccgtcga gcagcccggg cgggatgtgc tgcacgacgg cgtgccggca 780
cggggcgtcg gccgcgagcg tggcgttgtt cgcgccgccc cagacgtaga cggcgccggg 840
gtcgcgcagc tcccagcgga gcgagccgtt gtgcgcggtg gcgcggacgc acgcacagcg 900
ctggcagcgg gcggcgagcg cggcccacag cgccagcgcg aggtgggccg tgagcagcgc 960
cagcgcggcc aagttaacag tccgcccccc gagcagcat 999
<210> 4
<211> 2799
<212> DNA
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 4
atggccgctc gcggcggtgc tgaacgcgcc gcgggcgccg gagacggtcg gcgaggacag 60
cgtcgtcatc tacgaccggg acgtgttctc gctgctctac gcggtcctgc agcgcctggc 120
gccggcgggg cgcgcgccgc gctagccgct gccctgctat gggcgacgtg ggccctgctg 180
ctggcggcgc ccgccgcggg gcgaccggcg acaacgcccc cggcgccccc gcccgaagag 240
gccgcgagcc cggcgccccc cgcgagcccc agcccccccg gccccgacgg cgacgacgcc 300
gccagccccg acaacagcac agacgtgcgc gccgcgctcc ggctcgcgca ggcggccggg 360
gaaaactcgc gcttcttcgt gtgcccgccg ccctcgggcg ccacggtggt ccggctcgcg 420
cccgcgcggc cgtgccctga gtacgggctc gggcggaact acacggaggg catcggcgtc 480
atttacaagg agaacatcgc gccgtacacg ttcaaggcct acatttacaa aaacgtgatc 540
gtgaccacga cctgggcggg cagcacgtac gcggccatta caaaccagta cacggaccgc 600
gtgcccgtgg gcatgggcga gatcacggac ctggtggaca agaagtggcg ctgcctttcg 660
aaagccgagt acctgcgcag cgggcgcaag gtggtggcct ttgaccgcga cgacgacccc 720
tgggaggcgc cgctgaagcc tgcgcggctg agcgcgcccg gggtgcgggg ctggcacacg 780
acggacgatg tgtacacggc gctgggctcg gcggggctct accgcacggg cacctctgtg 840
aactgcatcg tggaagaagt ggaggcgcgc tcggtgtacc cgtacgactc gttcgcgctc 900
tcgaccgggg acattatcta catgtcgccc ttttacgggc tgcgcgaggg cgcgcaccgc 960
gagcacacca gctactcgcc ggagcgcttc cagcagatcg agggctacta caagcgcgac 1020
atggccacgg gccggcgcct caaggagccg gtctcgcgga actttttgcg tacacagcac 1080
gtgacggtag cctgggactg ggtgcccaag cgcaaaaacg tgtgctcgct ggccaagtgg 1140
cgcgaggcgg acgaaatgct gcgagacgag agccgcggga acttccgctt cacggcccgc 1200
tcgctctcgg cgacctttgt gagcgacagc cacaccttcg cgttgcagaa tgtgccgctg 1260
agcgactgcg tgatcgaaga ggccgaggcc gcggtcgagc gcgtctaccg cgagcgctac 1320
aacggcacgc acgtgctgtc gggcagcttg gagacgtacc tggcgcgcgg cggctttgtc 1380
gtggccttcc ggccgatgct cagcaacgag ctggccaagc tgtacctgca ggagctggcg 1440
cgctcgaacg gcacgctcga ggggctgttc gccgccgcgg cgcccaagcc gggcccgcgg 1500
cgcgcgcgcc gcgccgcgcc gtctgcgccc ggcggcccgg gcgcggccaa cgggcccgcc 1560
ggcgacggcg acgccggcgg gcgggtgact accgtgagct cggccgagtt tccggcgctg 1620
cagttcacct acgaccacat ccaggaccac gtgaacacca tgttcagccg cctggccacg 1680
tcctggtgcc tgctgcagaa caaggagcgc gccctgtggg ccgaggcggc taagctcaac 1740
cccagcgcgg cggccagcgc tgcgctggac cgccgcgccg ccgcgcgcat gttgggggac 1800
gccatggccg tgacgtactg ccacgagctg ggcgaggggc gcgtgttcat cgagaactcg 1860
atgcgcgcgc ccggcggcgt ttgctacagc cgcccgccgg tctcctttgc cttcggcaac 1920
gagagcgagc cggtggaggg ccagctcggc gaggacaacg agctgctgcc gggccgcgag 1980
ctcgtggagc cctgcaccgc caaccacaag cgctacttcc gctttggcgc ggactacgtg 2040
tactacgaga actacgcgta cgtgcggcgg gtcccgctcg cggagctgga ggtgatcagc 2100
acctttgtgg acctaaacct cacggttctg gaggaccgcg agttcttgcc gctagaagtg 2160
tacacgcgcg ccgagctcgc cgacacgggt ctgctcgact acagcgagat acagcgccgc 2220
aaccagctgc acgagctccg gttctacgac attgaccgcg tggtcaagac ggacggcaat 2280
atggccatca tgcgagggct cgccaacttc tttcagggcc tgggcgccgt cgggcaggcg 2340
gtgggcacgg tggtgctggg cgccgcgggt gccgcgctct cgaccgtgtc gggcatcgcc 2400
tcgtttattg cgaacccgtt cggcgcgctg gccacggggc tgctggtgct cgccgggctg 2460
gtggccgctt tcctggcgta ccggtacatt tcccgcctcc gcagcaaccc catgaaggcg 2520
ctgtacccga tcaccacgcg cgcgctcaag gacgacgccc ggggcgcaac cgccccgggc 2580
gaggaagagg aggagtttga cgcggccaaa ctggagcagg cccgcgagat gatcaagtat 2640
atgtcgctcg tgtcagcggt cgagcggcaa gagcacaagg cgaaaaagag caacaagggc 2700
ggcccgctgc tggcgacccg gctgacgcag ctcgcgcttc ggcggcgagc gccgccggag 2760
taccagcagc ttccgatggc cgacgtcggg ggggcatga 2799
<210> 5
<211> 1237
<212> DNA
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 5
ttagcggtat ggttggcggg cggggccggg cgtccgcctc gtacacggcc tcctcgtcgt 60
cagaggcgac gccgcggtcc agcagcgccg ctgcgtcgcc ttcgagcggg gccatgccgc 120
ggctgctgcg cgctcgggcg atgtagcgcg ccgcttgctg tcgcgcggcg ctcacgtggc 180
cgtagaaggc gctgcctttg cgccggtggt gcaggcaggc gcgcaccaac cgcagcacga 240
gcatggccac ggccagcagg gcgacgccgg ccagcgccag ctttacccta gcggcagccc 300
ggggggcctg cgtgcgcaca accccccgca gctggtggaa gtagtcgtgc gaggcgaccg 360
cgatgcagct agctgccacc agcgttccaa aggccggccc gggcagcact tgcgtgtagc 420
gcgacaggac tagctcggtc agtaccaaaa agagcacggc ggcgaggcag aagaccgtca 480
cgccggcgac gaccgtttgt gccagcgaca gccccagccc ggcccccagc agctggccga 540
gcatcagggg cgcggtgcca atgatcagcg ccagcaggcc gccggccagg ttgatcatca 600
cggcgcgccc ggggcccagc aggcggtggg cgcgcgggct cctctcgcgg agggcgtgca 660
cggcctgcgc gtactcggcg ccgggcagcc cggcggtgca aaagagcccg acgaaggcgg 720
ccggcggcgc caggtgcgcg aggtaggtgg ccgcggccaa gaccatgatc ttgtgggaca 780
gcagcagcac ggccgcctgc agcgtccagg ccgccagcgc gcccagcagc agcgcacccg 840
ggggcgtggc aagcgtcgcc agcgcgttca tatgatacgc cgccgcaaaa ccccctgagt 900
tttcgcggcg aatgattata gcggccgcga cgtcaaaggc ggcgacggcg agcagaacta 960
cggccgtgta cgcggagaag gccgctgtgg tcggcgtctc caaaaacagc gccgggtggc 1020
gcgcgccgag ctcccgctgc gcccaggcgc cgccgtcggc cgagaggttc cgcgcattgt 1080
aattaactat ggccgcgtag aagcagggga gccccgcgcc cggcgaagcg gcgccgatca 1140
gggtgatcag cagcagcagc gccagcgcgg cgaagacgcc gacctgagcg agccacaagc 1200
gccagtgcac ggcggcaggc tgcgcggagc ccgccat 1237
<210> 6
<211> 2219
<212> DNA
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 6
atggacgccg ctagggatgg gcggcctgag cgccgccgcg ccgtctccgg aacgtaccgc 60
acgcacccgt tccagcgccc ctctgcccgg cggagcgctg gacgccctgc gcgctgcgga 120
cgccgaggcc gcggagcgcc gcgggtccgg cgcccgcggc ctgacttcca gcggcccccg 180
gacgaggaca ccagtgagga cgagaacgtg tatgattaca tcgacggcga tagcagcgac 240
agcgccgacg actatgatag cgattatttt actgctaacc gcggccccaa tcacggcgcc 300
ggcgatgcta tggacacaga cgcaccaccc gagcgcgccc cggaaggggg tgccccgcaa 360
gactacttga cggcccacct gcgcgccatc gaggccctgc ccgagtcagc gccccaccgg 420
agcctgctgg agcgcacggc ccggaccgtg tatgcgcagc agtttccccc gcgcgatttg 480
agtgcgggct ccagggcgcc ggcacagcgc gcgcggcgga gcctccgcgg cttcccgcgt 540
ggcggcgggg gcggccagga acccgggcca gacgacgaag gcgacgacgc cgcagacctg 600
cgcgaggacc ttgtgccaga tgaggcctac gcgcacctag agcgcgacga gcggctgtcg 660
gaagggcccc cgctcctcaa catggaggcg gccgctgcgg ctgcggggga gaggagcgtg 720
gtggaggagc tgtttacgta cgcccctgcc cagcctcagg tagaggtgcc gctgcccagg 780
attttggagg gccgggtgcg gcccagcgcc ttcttcgcgc agatgccgct ggacgcgctg 840
tgccgcacgc cgcccaacga tcagcgcgtg gtgcgcgagc ggcgcgcttg ggagatggcc 900
ggtacgccgc atgggctcct aataaccacg tggagcacgg tggacccgga attctcgatc 960
ggcggcatgt acgtgggcgc ccctgagggc acccggcccc ggctagtgtg gcggcgcgcg 1020
atgaagcagg ccatggcgct gcagtaccgg ctgggggtgg ggggcctgtg ccgagcagta 1080
gacggcgcag catgccgccc actgaggcgc tgctcttttt ggcgggacgc gctgctgcgc 1140
gagtgcgcaa ctgccatttt ttgtcgcggc cggggcgcgc gggcggcgcc gcgccgcctg 1200
ccgcggtcgg cggttgggct gctggcagcc acgcagttca cgccaccgga cgcgtccccc 1260
cacgcgacgc tctttcgcgg ctcaatgggc tccctgattt actggcacga gctgcgcgtg 1320
atgctgactg cggtgccggc cctgtgcgcg cgctacgcgg gcgccgggct gcagtcggcc 1380
gagctgtacc tgctggcgct agcgcactca gaggcgcccg gctacacggc aaatgagcgc 1440
tacgcgctct cggcgtacct gacgctgttt gtagcgctcg cggagcgggc gctgcgctgg 1500
ctgtatctag cgggcgcgca cctgctcggg ccgcacccca cagcggcggc cttccgcgaa 1560
gtgcgcgcca agatcccgta cgagcggctg ccgctaggca gcgcgacgct gcacgacgcc 1620
gaagtggaga cggtggactc ggccaccttc caggaggccc tggcttttag cgcgctggca 1680
catgtttacg gggaggccta cgtagcggtg cggaccgcga cgacgctgct gatggccgag 1740
tacgcggccc acgctgagcg ccgggacgtg cgcgagatga cagcggcctt cctgggcgtg 1800
gggctgatcg cgcagcggct gatgggcagc ctgaacctgc tgctgaactg cgtagccggc 1860
gcagcggtgt acgggggccg gcgtgtgacg gtgcgcgagg gcacgctcgc gcggtacagc 1920
ctgctagcgg acgcggcact gccgctggtg cgcccggtgt ccctggtgga gttctgggag 1980
gcccgcgacg gcgtcatgcg cgagctgcgg ctgcggcccg tggcgagccc gcccctggcc 2040
ggcaagcggc gggtcatgga gctgtacctc tcgctggaca gcatagaggc gctggtcggc 2100
cgcgagccgc taggttcgcg gccggtgctt gggccgctcg tggacatcgc ggaggcgctg 2160
gcggaccacc cgcacctcgt cacgggcgat gggcggggcc cgcgcctggg cggccgcta 2219
<210> 7
<211> 332
<212> PRT
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 7
Met Leu Leu Gly Gly Arg Thr Val Asn Leu Ala Ala Leu Ala Leu Leu
1 5 10 15
Thr Ala His Leu Ala Leu Ala Leu Trp Ala Ala Leu Ala Ala Arg Cys
20 25 30
Gln Arg Cys Ala Cys Val Arg Ala Thr Ala His Asn Gly Ser Leu Arg
35 40 45
Trp Glu Leu Arg Asp Pro Gly Ala Val Tyr Val Trp Gly Gly Ala Asn
50 55 60
Asn Ala Thr Leu Ala Ala Asp Ala Pro Cys Arg His Ala Val Val Gln
65 70 75 80
His Ile Pro Pro Gly Leu Leu Asp Gly Asp Glu Ala Leu His Gly Arg
85 90 95
Val Arg Ala Val Ala Gly Ala Arg Asp Cys Arg Ala Tyr Leu Trp Ser
100 105 110
Ala Gln Ala Arg Ser Ala Leu Leu Ala Trp Leu Leu Tyr Val Ala Phe
115 120 125
Val Tyr Leu Arg Gln Glu Arg Arg Met Phe Gly Ile Cys Arg Asn Asp
130 135 140
Ala Asp Phe Leu Ser Pro Gly Gly Tyr Thr Leu Asn Tyr Ala Ala Ala
145 150 155 160
Ala Leu Ala Ala Val Val Gly His Gly Pro Tyr Thr Lys Leu Ala Arg
165 170 175
Leu Met Cys Glu Leu Ser Ala Arg Arg Arg Ala Leu Ala Val Asn Phe
180 185 190
Arg Leu Asp Pro Leu Gly Cys Ala Trp Arg Pro Arg Ala Ala Leu Pro
195 200 205
Leu Leu Ala Glu Gly Leu Ala Arg Leu Gly Ala Arg Ile Ala Ala Ala
210 215 220
Ser Ser Val Gly Ile Thr His Pro Cys Ala Ala Ala Tyr Pro Leu Tyr
225 230 235 240
Leu Lys Ile Trp Ala Trp Val His Val Ala Leu Phe Ala Gly Leu Glu
245 250 255
Leu Val Ser Leu Leu Tyr Arg Lys Pro Arg Arg Arg Gly Gly Thr Cys
260 265 270
Ala Gly Asp Gly Gly Asp Gly Gly Glu Ser Gly Ile Arg Lys Val Cys
275 280 285
Val Asn Cys Cys Ser Thr Leu Leu Ala Gly Leu Leu Val Lys Ala Leu
290 295 300
Tyr Leu Ala Ala Ile Val Gly Gly Val Ile Ala Leu Leu His Tyr Glu
305 310 315 320
His Asn Leu Arg Leu Arg Leu Leu Gly Ala Gln Thr
325 330
<210> 8
<211> 932
<212> PRT
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 8
Met Ala Ala Arg Gly Gly Ala Glu Arg Ala Ala Gly Ala Gly Asp Gly
1 5 10 15
Arg Arg Gly Gln Arg Arg His Leu Arg Pro Gly Arg Val Leu Ala Ala
20 25 30
Leu Arg Gly Pro Ala Ala Pro Gly Ala Gly Gly Ala Arg Ala Ala Leu
35 40 45
Ala Ala Ala Leu Leu Trp Ala Thr Trp Ala Leu Leu Leu Ala Ala Pro
50 55 60
Ala Ala Gly Arg Pro Ala Thr Thr Pro Pro Ala Pro Pro Pro Glu Glu
65 70 75 80
Ala Ala Ser Pro Ala Pro Pro Ala Ser Pro Ser Pro Pro Gly Pro Asp
85 90 95
Gly Asp Asp Ala Ala Ser Pro Asp Asn Ser Thr Asp Val Arg Ala Ala
100 105 110
Leu Arg Leu Ala Gln Ala Ala Gly Glu Asn Ser Arg Phe Phe Val Cys
115 120 125
Pro Pro Pro Ser Gly Ala Thr Val Val Arg Leu Ala Pro Ala Arg Pro
130 135 140
Cys Pro Glu Tyr Gly Leu Gly Arg Asn Tyr Thr Glu Gly Ile Gly Val
145 150 155 160
Ile Tyr Lys Glu Asn Ile Ala Pro Tyr Thr Phe Lys Ala Tyr Ile Tyr
165 170 175
Lys Asn Val Ile Val Thr Thr Thr Trp Ala Gly Ser Thr Tyr Ala Ala
180 185 190
Ile Thr Asn Gln Tyr Thr Asp Arg Val Pro Val Gly Met Gly Glu Ile
195 200 205
Thr Asp Leu Val Asp Lys Lys Trp Arg Cys Leu Ser Lys Ala Glu Tyr
210 215 220
Leu Arg Ser Gly Arg Lys Val Val Ala Phe Asp Arg Asp Asp Asp Pro
225 230 235 240
Trp Glu Ala Pro Leu Lys Pro Ala Arg Leu Ser Ala Pro Gly Val Arg
245 250 255
Gly Trp His Thr Thr Asp Asp Val Tyr Thr Ala Leu Gly Ser Ala Gly
260 265 270
Leu Tyr Arg Thr Gly Thr Ser Val Asn Cys Ile Val Glu Glu Val Glu
275 280 285
Ala Arg Ser Val Tyr Pro Tyr Asp Ser Phe Ala Leu Ser Thr Gly Asp
290 295 300
Ile Ile Tyr Met Ser Pro Phe Tyr Gly Leu Arg Glu Gly Ala His Arg
305 310 315 320
Glu His Thr Ser Tyr Ser Pro Glu Arg Phe Gln Gln Ile Glu Gly Tyr
325 330 335
Tyr Lys Arg Asp Met Ala Thr Gly Arg Arg Leu Lys Glu Pro Val Ser
340 345 350
Arg Asn Phe Leu Arg Thr Gln His Val Thr Val Ala Trp Asp Trp Val
355 360 365
Pro Lys Arg Lys Asn Val Cys Ser Leu Ala Lys Trp Arg Glu Ala Asp
370 375 380
Glu Met Leu Arg Asp Glu Ser Arg Gly Asn Phe Arg Phe Thr Ala Arg
385 390 395 400
Ser Leu Ser Ala Thr Phe Val Ser Asp Ser His Thr Phe Ala Leu Gln
405 410 415
Asn Val Pro Leu Ser Asp Cys Val Ile Glu Glu Ala Glu Ala Ala Val
420 425 430
Glu Arg Val Tyr Arg Glu Arg Tyr Asn Gly Thr His Val Leu Ser Gly
435 440 445
Ser Leu Glu Thr Tyr Leu Ala Arg Gly Gly Phe Val Val Ala Phe Arg
450 455 460
Pro Met Leu Ser Asn Glu Leu Ala Lys Leu Tyr Leu Gln Glu Leu Ala
465 470 475 480
Arg Ser Asn Gly Thr Leu Glu Gly Leu Phe Ala Ala Ala Ala Pro Lys
485 490 495
Pro Gly Pro Arg Arg Ala Arg Arg Ala Ala Pro Ser Ala Pro Gly Gly
500 505 510
Pro Gly Ala Ala Asn Gly Pro Ala Gly Asp Gly Asp Ala Gly Gly Arg
515 520 525
Val Thr Thr Val Ser Ser Ala Glu Phe Pro Ala Leu Gln Phe Thr Tyr
530 535 540
Asp His Ile Gln Asp His Val Asn Thr Met Phe Ser Arg Leu Ala Thr
545 550 555 560
Ser Trp Cys Leu Leu Gln Asn Lys Glu Arg Ala Leu Trp Ala Glu Ala
565 570 575
Ala Lys Leu Asn Pro Ser Ala Ala Ala Ser Ala Ala Leu Asp Arg Arg
580 585 590
Ala Ala Ala Arg Met Leu Gly Asp Ala Met Ala Val Thr Tyr Cys His
595 600 605
Glu Leu Gly Glu Gly Arg Val Phe Ile Glu Asn Ser Met Arg Ala Pro
610 615 620
Gly Gly Val Cys Tyr Ser Arg Pro Pro Val Ser Phe Ala Phe Gly Asn
625 630 635 640
Glu Ser Glu Pro Val Glu Gly Gln Leu Gly Glu Asp Asn Glu Leu Leu
645 650 655
Pro Gly Arg Glu Leu Val Glu Pro Cys Thr Ala Asn His Lys Arg Tyr
660 665 670
Phe Arg Phe Gly Ala Asp Tyr Val Tyr Tyr Glu Asn Tyr Ala Tyr Val
675 680 685
Arg Arg Val Pro Leu Ala Glu Leu Glu Val Ile Ser Thr Phe Val Asp
690 695 700
Leu Asn Leu Thr Val Leu Glu Asp Arg Glu Phe Leu Pro Leu Glu Val
705 710 715 720
Tyr Thr Arg Ala Glu Leu Ala Asp Thr Gly Leu Leu Asp Tyr Ser Glu
725 730 735
Ile Gln Arg Arg Asn Gln Leu His Glu Leu Arg Phe Tyr Asp Ile Asp
740 745 750
Arg Val Val Lys Thr Asp Gly Asn Met Ala Ile Met Arg Gly Leu Ala
755 760 765
Asn Phe Phe Gln Gly Leu Gly Ala Val Gly Gln Ala Val Gly Thr Val
770 775 780
Val Leu Gly Ala Ala Gly Ala Ala Leu Ser Thr Val Ser Gly Ile Ala
785 790 795 800
Ser Phe Ile Ala Asn Pro Phe Gly Ala Leu Ala Thr Gly Leu Leu Val
805 810 815
Leu Ala Gly Leu Val Ala Ala Phe Leu Ala Tyr Arg Tyr Ile Ser Arg
820 825 830
Leu Arg Ser Asn Pro Met Lys Ala Leu Tyr Pro Ile Thr Thr Arg Ala
835 840 845
Leu Lys Asp Asp Ala Arg Gly Ala Thr Ala Pro Gly Glu Glu Glu Glu
850 855 860
Glu Phe Asp Ala Ala Lys Leu Glu Gln Ala Arg Glu Met Ile Lys Tyr
865 870 875 880
Met Ser Leu Val Ser Ala Val Glu Arg Gln Glu His Lys Ala Lys Lys
885 890 895
Ser Asn Lys Gly Gly Pro Leu Leu Ala Thr Arg Leu Thr Gln Leu Ala
900 905 910
Leu Arg Arg Arg Ala Pro Pro Glu Tyr Gln Gln Leu Pro Met Ala Asp
915 920 925
Val Gly Gly Ala
930
<210> 9
<211> 412
<212> PRT
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 9
Met Ala Gly Ser Ala Gln Pro Ala Ala Val His Trp Arg Leu Trp Leu
1 5 10 15
Ala Gln Val Gly Val Phe Ala Ala Leu Ala Leu Leu Leu Leu Ile Thr
20 25 30
Leu Ile Gly Ala Ala Ser Pro Gly Ala Gly Leu Pro Cys Phe Tyr Ala
35 40 45
Ala Ile Val Asn Tyr Asn Ala Arg Asn Leu Ser Ala Asp Gly Gly Ala
50 55 60
Trp Ala Gln Arg Glu Leu Gly Ala Arg His Pro Ala Leu Phe Leu Glu
65 70 75 80
Thr Pro Thr Thr Ala Ala Phe Ser Ala Tyr Thr Ala Val Val Leu Leu
85 90 95
Ala Val Ala Ala Phe Asp Val Ala Ala Ala Ile Ile Ile Arg Arg Glu
100 105 110
Asn Ser Gly Gly Phe Ala Ala Ala Tyr His Met Asn Ala Leu Ala Thr
115 120 125
Leu Ala Thr Pro Pro Gly Ala Leu Leu Leu Gly Ala Leu Ala Ala Trp
130 135 140
Thr Leu Gln Ala Ala Val Leu Leu Leu Ser His Lys Ile Met Val Leu
145 150 155 160
Ala Ala Ala Thr Tyr Leu Ala His Leu Ala Pro Pro Ala Ala Phe Val
165 170 175
Gly Leu Phe Cys Thr Ala Gly Leu Pro Gly Ala Glu Tyr Ala Gln Ala
180 185 190
Val His Ala Leu Arg Glu Arg Ser Pro Arg Ala His Arg Leu Leu Gly
195 200 205
Pro Gly Arg Ala Val Met Ile Asn Leu Ala Gly Gly Leu Leu Ala Leu
210 215 220
Ile Ile Gly Thr Ala Pro Leu Met Leu Gly Gln Leu Leu Gly Ala Gly
225 230 235 240
Leu Gly Leu Ser Leu Ala Gln Thr Val Val Ala Gly Val Thr Val Phe
245 250 255
Cys Leu Ala Ala Val Leu Phe Leu Val Leu Thr Glu Leu Val Leu Ser
260 265 270
Arg Tyr Thr Gln Val Leu Pro Gly Pro Ala Phe Gly Thr Leu Val Ala
275 280 285
Ala Ser Cys Ile Ala Val Ala Ser His Asp Tyr Phe His Gln Leu Arg
290 295 300
Gly Val Val Arg Thr Gln Ala Pro Arg Ala Ala Ala Arg Val Lys Leu
305 310 315 320
Ala Leu Ala Gly Val Ala Leu Leu Ala Val Ala Met Leu Val Leu Arg
325 330 335
Leu Val Arg Ala Cys Leu His His Arg Arg Lys Gly Ser Ala Phe Tyr
340 345 350
Gly His Val Ser Ala Ala Arg Gln Gln Ala Ala Arg Tyr Ile Ala Arg
355 360 365
Ala Arg Ser Ser Arg Gly Met Ala Pro Leu Glu Gly Asp Ala Ala Ala
370 375 380
Leu Leu Asp Arg Gly Val Ala Ser Asp Asp Glu Glu Ala Val Tyr Glu
385 390 395 400
Ala Asp Ala Arg Pro Arg Pro Pro Thr Ile Pro Leu
405 410
<210> 10
<211> 739
<212> PRT
<213> Bovine herpes virus type 1 (Bovine herpesvirus 1)
<400> 10
Met Asp Ala Ala Arg Asp Gly Arg Pro Glu Arg Arg Arg Ala Val Ser
1 5 10 15
Gly Thr Tyr Arg Thr His Pro Phe Gln Arg Pro Ser Ala Arg Arg Ser
20 25 30
Ala Gly Arg Pro Ala Arg Cys Gly Arg Arg Gly Arg Gly Ala Pro Arg
35 40 45
Val Arg Arg Pro Arg Pro Asp Phe Gln Arg Pro Pro Asp Glu Asp Thr
50 55 60
Ser Glu Asp Glu Asn Val Tyr Asp Tyr Ile Asp Gly Asp Ser Ser Asp
65 70 75 80
Ser Ala Asp Asp Tyr Asp Ser Asp Tyr Phe Thr Ala Asn Arg Gly Pro
85 90 95
Asn His Gly Ala Gly Asp Ala Met Asp Thr Asp Ala Pro Pro Glu Arg
100 105 110
Ala Pro Glu Gly Gly Ala Pro Gln Asp Tyr Leu Thr Ala His Leu Arg
115 120 125
Ala Ile Glu Ala Leu Pro Glu Ser Ala Pro His Arg Ser Leu Leu Glu
130 135 140
Arg Thr Ala Arg Thr Val Tyr Ala Gln Gln Phe Pro Pro Arg Asp Leu
145 150 155 160
Ser Ala Gly Ser Arg Ala Pro Ala Gln Arg Ala Arg Arg Ser Leu Arg
165 170 175
Gly Phe Pro Arg Gly Gly Gly Gly Gly Gln Glu Pro Gly Pro Asp Asp
180 185 190
Glu Gly Asp Asp Ala Ala Asp Leu Arg Glu Asp Leu Val Pro Asp Glu
195 200 205
Ala Tyr Ala His Leu Glu Arg Asp Glu Arg Leu Ser Glu Gly Pro Pro
210 215 220
Leu Leu Asn Met Glu Ala Ala Ala Ala Ala Ala Gly Glu Arg Ser Val
225 230 235 240
Val Glu Glu Leu Phe Thr Tyr Ala Pro Ala Gln Pro Gln Val Glu Val
245 250 255
Pro Leu Pro Arg Ile Leu Glu Gly Arg Val Arg Pro Ser Ala Phe Phe
260 265 270
Ala Gln Met Pro Leu Asp Ala Leu Cys Arg Thr Pro Pro Asn Asp Gln
275 280 285
Arg Val Val Arg Glu Arg Arg Ala Trp Glu Met Ala Gly Thr Pro His
290 295 300
Gly Leu Leu Ile Thr Thr Trp Ser Thr Val Asp Pro Glu Phe Ser Ile
305 310 315 320
Gly Gly Met Tyr Val Gly Ala Pro Glu Gly Thr Arg Pro Arg Leu Val
325 330 335
Trp Arg Arg Ala Met Lys Gln Ala Met Ala Leu Gln Tyr Arg Leu Gly
340 345 350
Val Gly Gly Leu Cys Arg Ala Val Asp Gly Ala Ala Cys Arg Pro Leu
355 360 365
Arg Arg Cys Ser Phe Trp Arg Asp Ala Leu Leu Arg Glu Cys Ala Thr
370 375 380
Ala Ile Phe Cys Arg Gly Arg Gly Ala Arg Ala Ala Pro Arg Arg Leu
385 390 395 400
Pro Arg Ser Ala Val Gly Leu Leu Ala Ala Thr Gln Phe Thr Pro Pro
405 410 415
Asp Ala Ser Pro His Ala Thr Leu Phe Arg Gly Ser Met Gly Ser Leu
420 425 430
Ile Tyr Trp His Glu Leu Arg Val Met Leu Thr Ala Val Pro Ala Leu
435 440 445
Cys Ala Arg Tyr Ala Gly Ala Gly Leu Gln Ser Ala Glu Leu Tyr Leu
450 455 460
Leu Ala Leu Ala His Ser Glu Ala Pro Gly Tyr Thr Ala Asn Glu Arg
465 470 475 480
Tyr Ala Leu Ser Ala Tyr Leu Thr Leu Phe Val Ala Leu Ala Glu Arg
485 490 495
Ala Leu Arg Trp Leu Tyr Leu Ala Gly Ala His Leu Leu Gly Pro His
500 505 510
Pro Thr Ala Ala Ala Phe Arg Glu Val Arg Ala Lys Ile Pro Tyr Glu
515 520 525
Arg Leu Pro Leu Gly Ser Ala Thr Leu His Asp Ala Glu Val Glu Thr
530 535 540
Val Asp Ser Ala Thr Phe Gln Glu Ala Leu Ala Phe Ser Ala Leu Ala
545 550 555 560
His Val Tyr Gly Glu Ala Tyr Val Ala Val Arg Thr Ala Thr Thr Leu
565 570 575
Leu Met Ala Glu Tyr Ala Ala His Ala Glu Arg Arg Asp Val Arg Glu
580 585 590
Met Thr Ala Ala Phe Leu Gly Val Gly Leu Ile Ala Gln Arg Leu Met
595 600 605
Gly Ser Leu Asn Leu Leu Leu Asn Cys Val Ala Gly Ala Ala Val Tyr
610 615 620
Gly Gly Arg Arg Val Thr Val Arg Glu Gly Thr Leu Ala Arg Tyr Ser
625 630 635 640
Leu Leu Ala Asp Ala Ala Leu Pro Leu Val Arg Pro Val Ser Leu Val
645 650 655
Glu Phe Trp Glu Ala Arg Asp Gly Val Met Arg Glu Leu Arg Leu Arg
660 665 670
Pro Val Ala Ser Pro Pro Leu Ala Gly Lys Arg Arg Val Met Glu Leu
675 680 685
Tyr Leu Ser Leu Asp Ser Ile Glu Ala Leu Val Gly Arg Glu Pro Leu
690 695 700
Gly Ser Arg Pro Val Leu Gly Pro Leu Val Asp Ile Ala Glu Ala Leu
705 710 715 720
Ala Asp His Pro His Leu Val Thr Gly Asp Gly Arg Gly Pro Arg Leu
725 730 735
Gly Gly Arg

Claims (5)

1. A Bovine herpes virus type 1 (BoHV-1) strain is named as BoHV-1/Goat/CHN/HB01/2016 and is deposited in China center for type culture Collection with the preservation number of CCTCC NO: v202092.
2. The bovine herpes virus type 1 strain of claim 1 which is: the strain is separated from diarrhea goat excrement and is a goat-derived bovine herpes virus type 1 strain.
3. The bovine herpes virus type 1 strain of claim 2 which is: the amino acid sequences of gK, gB, gM and VP8 proteins of the strain are respectively shown in SEQ ID NO. 7-10.
4. Use of the strain of claim 1 in the study of the pathogenesis and cross-species transmission mechanism of bovine herpes virus type 1.
5. Use of the strain of claim 1 which is attenuated for its virulence in the preparation of a bovine herpes virus type 1 vaccine.
CN202110301274.4A 2021-03-22 2021-03-22 Goat-derived bovine herpes virus type 1 strain and application thereof Pending CN113061581A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110301274.4A CN113061581A (en) 2021-03-22 2021-03-22 Goat-derived bovine herpes virus type 1 strain and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110301274.4A CN113061581A (en) 2021-03-22 2021-03-22 Goat-derived bovine herpes virus type 1 strain and application thereof

Publications (1)

Publication Number Publication Date
CN113061581A true CN113061581A (en) 2021-07-02

Family

ID=76562835

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110301274.4A Pending CN113061581A (en) 2021-03-22 2021-03-22 Goat-derived bovine herpes virus type 1 strain and application thereof

Country Status (1)

Country Link
CN (1) CN113061581A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113388588A (en) * 2021-07-06 2021-09-14 天康制药(苏州)有限公司 Recombinant bovine herpes simplex virus expressing bovine herpes simplex virus type I gB gene and application thereof
CN116042536A (en) * 2022-08-02 2023-05-02 大能生物科技(南京)有限公司 Bovine herpesvirus 4 strain and culture method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000234A2 (en) * 1999-06-25 2001-01-04 Maxygen, Inc. Methods and compositions for engineering of attenuated vaccines
US20040185056A1 (en) * 2003-01-03 2004-09-23 Board Of Regents, University Of Nebraska-Lincoln Vaccines containing bovine herpesvirus 1 attenuated by mutation in latency-related gene
WO2011026882A1 (en) * 2009-09-03 2011-03-10 Intervet International B.V. Bovine herpesvirus vaccine
CN104928260A (en) * 2015-06-01 2015-09-23 何洪彬 Infectious bovine rhinotracheitis virus IBRV-JN03 isolate and application thereof
CN107815439A (en) * 2016-09-14 2018-03-20 华威特(江苏)生物制药有限公司 Infectious bovine rhinotrachetis virus JSM strains and its application

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000234A2 (en) * 1999-06-25 2001-01-04 Maxygen, Inc. Methods and compositions for engineering of attenuated vaccines
US20040185056A1 (en) * 2003-01-03 2004-09-23 Board Of Regents, University Of Nebraska-Lincoln Vaccines containing bovine herpesvirus 1 attenuated by mutation in latency-related gene
WO2011026882A1 (en) * 2009-09-03 2011-03-10 Intervet International B.V. Bovine herpesvirus vaccine
CN104928260A (en) * 2015-06-01 2015-09-23 何洪彬 Infectious bovine rhinotracheitis virus IBRV-JN03 isolate and application thereof
CN107815439A (en) * 2016-09-14 2018-03-20 华威特(江苏)生物制药有限公司 Infectious bovine rhinotrachetis virus JSM strains and its application

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
FARZANA SHAHIN等: "Bovine herpesvirus 1 tegument protein UL21 plays critical roles in viral secondary envelopment and cell-to-cell spreading", 《ONCOTARGET》 *
刘瑞宁等: "牛传染性鼻气管炎疫苗研究进展", 《动物医学进展》 *
郭利等: "不同毒力牛传染性鼻气管炎病毒感染MDBK细胞的差异蛋白组学", 《中国兽医学报》 *
郭利等: "牛传染性鼻气管炎弱毒活疫苗的安全性和免疫保护效果", 《中国兽医科学》 *
郭利等: "牛传染性鼻气管炎病毒LNM株致弱疫苗免疫效力的研究", 《中国预防兽医学报》 *
高兵等: "牛传染性鼻气管炎IBRV/JZ06-3基础毒株的安全性和免疫原性研究", 《特产研究》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113388588A (en) * 2021-07-06 2021-09-14 天康制药(苏州)有限公司 Recombinant bovine herpes simplex virus expressing bovine herpes simplex virus type I gB gene and application thereof
CN116042536A (en) * 2022-08-02 2023-05-02 大能生物科技(南京)有限公司 Bovine herpesvirus 4 strain and culture method and application thereof
CN116042536B (en) * 2022-08-02 2023-12-29 南京农业大学 Bovine herpesvirus 4 strain and culture method and application thereof

Similar Documents

Publication Publication Date Title
CN107815441B (en) Type II pseudorabies virus attenuated strain and preparation method and application thereof
Zhang et al. Biological and genetic characterization of a hemagglutinating coronavirus isolated from a diarrhoeic child
CN110551695A (en) African swine fever virus four-gene deletion low virulent strain and application thereof
CN109439634B (en) Pseudorabies virus gene engineering attenuated vaccine strain and application thereof
ES2774291T3 (en) Methods and compositions for the treatment and control of plant diseases
KR920000116B1 (en) Recombinant mareks disease virus and vaccine
CN113061581A (en) Goat-derived bovine herpes virus type 1 strain and application thereof
Borchers et al. Detection of equine herpesvirus types 2 and 5 (EHV-2 and EHV-5) in Przewalski’s wild horses
CN109136198B (en) Recombinant fowl pox virus live vector vaccine for expressing chicken infectious anemia virus VP1 and VP2 genes
CN114774372B (en) Coxsackie virus A10 type strain and vaccine and application thereof
AU2002247733B2 (en) Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
CN114807060B (en) Coxsackie virus A6 type strain and immunogenic composition and application thereof
Pierson et al. Hemorrhagic enteritis and related infections
Lin et al. Pseudorabies virus (PRV) strain with defects in gE, gC, and TK genes protects piglets against an emerging PRV variant
CN104152416A (en) Pseudorabies virus gene-deleted attenuated strain as well as preparation method and application thereof
CN106939320B (en) Infectious clone plasmid of pseudorabies virus JS-2012 strain, construction method and application
CN113564133B (en) Coxsackie virus A16 type strain and immunogenic composition and application thereof
CN109402065B (en) Muscovy duck subtype C avian metapneumovirus attenuated strain and preparation and application thereof
CN117230026B (en) Coxsackie virus A6 type CVA6-KM-J33 and application thereof
CN105802921B (en) Recombinant pseudorabies virus variant strain for expressing classical swine fever virus E2protein and construction method and application thereof
RUPASINGHE et al. Identification of the porcine cytomegalovirus major capsid protein gene
KR20210062015A (en) Modified PEDV Spike Protein
CN116042540A (en) Separation and application of cat rhinotracheitis virus FHV-1WH-2017 strain
Yokoyama et al. Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats
CN113637648A (en) Recombinant porcine pseudorabies virus strain capable of simultaneously expressing PEDV variant strain S1 gene CS region and porcine IL-18 and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210702